Teva Pharmaceutical Industries (NYSE:TEVA) Lowered to Hold at StockNews.com - Defense World
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
S&P cuts Teva's rating on rising litigation risks
Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan Nasal Spray
Buy Teva Sandal Tirra Blue/Coral from Canada at Well.ca - Free Shipping
Teva Pharmaceuticals Ratings Cut at Fitch - TheStreet
Teva Pharmaceutical (TEVA)
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
4 Analysts Have This to Say About Teva Pharmaceutical Indus | Markets Insider
Teva Europe (@tevapharmeurope) / Twitter
Moody's places Teva rating under review - Globes
Teva Faces Rocky Path to Recovery After Debt | Fortune